Cp55940
CP55940 is a synthetic cannabinoid receptor agonist. It functions as a potent and selective agonist for the CB1 and CB2 cannabinoid receptors.
Lab products found in correlation
21 protocols using cp55940
Dissolving Drugs for Behavioral Effects
Subcutaneous administration of morphine and CP55940
Cannabinoid Effects on Visual Cortex Neuronal Activity
Baseline neuronal responses were initially recorded in response to the pseudorandom checkerboard stimulus. Following this, the vehicle-only injection was administered and after 15 minutes, responses to visual stimuli were again recorded. Afterwards, a 0.3 mg/kg dose of CP55940 was delivered and 15 minutes later, three recording sessions (spontaneous activity and receptive field mapping) were completed. Each recording session lasted 22 minutes. The baseline and vehicle-only recordings were pooled to form the “control condition.” Similarly, the three post-CP55940 infusion recordings were pooled to form the cannabinoid condition. Pooling over datasets helped reduce the effect of variability in neuronal responses.
Natural Compound Library Preparation
Cell Lines and Reagents for Bioassays
Cannabinoid Receptor Binding Assay
(Temecula, CA, USA). [35S]GTPγS (1250 Ci/mmol) and
[3H]CP55,940 (131.8 Ci/mmol) were acquired from PerkinElmer
(Boston MA, USA). The [14C]-microscales, used as standards
in the autoradiographic experiments, were acquired from American Radiolabeled
Chemicals (St. Louis, MO, USA). Kodak Biomax MR β-radiation-sensitive
films, bovine serum albumin (BSA),
deaminase, guanosine 5′-diphosphate, guanosine 5′-O-3-thiotriphosphate
(GTPγS), ketamine and xylazine, as well as CP55,940 were acquired
from Sigma-Aldrich (St. Louis, MO, USA). SR141716A and HU308 were
acquired from Tocris Bioscience (Bristol, UK) and SR144528 from Cayman-Chemicals
(MI, USA). All the compounds used were of the highest commercially
available quality.
Osteoclastogenesis Assay Protocol
Synthesis and Characterization of Novel Cannabinoid Compounds
Pharmacological Modulation of Membrane Permeability
Pharmacological Evaluation of Remifentanil and Cannabinoids
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!